15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Veracyte Inc, 7 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $44.00 to $69.00, a moderate spread. The average target of $53.22 sits 25% above the current $42.46. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.45 next quarter toward $1.95 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy778%
Hold111%
Sell111%
Strong Sell00%
Based on 9 analysts giving stock ratings to Veracyte Inc.
As of Sep, 7 of 9 firms rate VCYT a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
VCYT EPS & revenue forecast
EPS · NEXT QUARTER
$0.45
Range $0.37 – $0.50 · 11 analysts · -15% YoY
Next period, 11 analysts expect Veracyte Inc to earn $0.45 a share (range $0.37 – $0.50), versus $0.53 a year earlier. Full-year consensus is $1.91, growing to $1.95 the year after.
REVENUE · NEXT QUARTER
$157.3M
Range $155.2M – $159.9M · 11 analysts · +12% YoY
Revenue is expected to reach $157.3M (range $155.2M – $159.9M), +11.9% year-over-year. Full-year consensus is $593.7M, rising to $659.9M next year.
Top analysts covering Veracyte Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VCYT.
#1
SJ
Sung Ji Nam
Scotiabank · Rank #140
Buy
$44.00+3.6% to target
Overall win rate
46%
+ Follow
#2
Mike Matson
Needham · Rank #210
Buy
$69.00+62.5% to target
Overall win rate
34%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #244
Buy
$54.00+27.2% to target
Overall win rate
33%
+ Follow
#4
KM
Kyle Mikson
Canaccord Genuity · Rank #263
Hold
$50.00+17.8% to target
Overall win rate
34%
+ Follow
#5
Matthew Sykes
Goldman Sachs · Rank #274
Hold
$37.00-12.9% to target
Overall win rate
38%
+ Follow
VCYT stock forecast FAQ
What is VCYT's average 12-month price target?+
The 9 analysts with a live target average $53.22 for Veracyte Inc over the next 12 months, ranging from a $69.00 high to a $44.00 low.
Is VCYT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 7 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for VCYT?+
The Street-high target is $69.00 (Needham), and the Street-low is $44.00 (Morgan Stanley). The average of all 9 active targets is $53.22.
How many Wall Street analysts cover VCYT?+
9 analysts have an active rating on Veracyte Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering VCYT?+
Among analysts who currently cover VCYT, Sung Ji Nam of Scotiabank has the strongest overall Quantellect track record (Rank #140). Their current call is Buy with a $44.00 target.
What is Veracyte Inc's projected EPS for next quarter?+
The consensus estimate is $0.45 per share (range $0.37 – $0.50) across 11 analysts. Full-year EPS is projected at $1.91, rising to $1.95 the following year.
How much revenue is Veracyte Inc expected to report next quarter?+
Consensus revenue is $157.3M (range $155.2M – $159.9M). Full-year revenue is projected at $593.7M, growing to $659.9M next year.
Have analysts been upgrading or downgrading VCYT lately?+
As of Sep, 7 of 9 firms rate VCYT a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VCYT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
